Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma
Clinical trial NCT06827782 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06827782
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-01
- Primary completion
- 2026-12-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.